ATE425962T1 - Peptid-deformylase-hemmer - Google Patents
Peptid-deformylase-hemmerInfo
- Publication number
- ATE425962T1 ATE425962T1 AT03719773T AT03719773T ATE425962T1 AT E425962 T1 ATE425962 T1 AT E425962T1 AT 03719773 T AT03719773 T AT 03719773T AT 03719773 T AT03719773 T AT 03719773T AT E425962 T1 ATE425962 T1 AT E425962T1
- Authority
- AT
- Austria
- Prior art keywords
- peptide deformylase
- deformylase inhibitors
- inhibitors
- peptide
- novel
- Prior art date
Links
- 239000000081 peptide deformylase inhibitor Substances 0.000 title 1
- 239000003112 inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/51—Y being a hydrogen or a carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2003/011704 WO2004098584A1 (en) | 2003-04-16 | 2003-04-16 | Peptide deformylase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE425962T1 true ATE425962T1 (de) | 2009-04-15 |
Family
ID=33434321
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03719773T ATE425962T1 (de) | 2003-04-16 | 2003-04-16 | Peptid-deformylase-hemmer |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7375120B2 (de) |
| EP (1) | EP1615629B1 (de) |
| JP (1) | JP4373343B2 (de) |
| AT (1) | ATE425962T1 (de) |
| AU (1) | AU2003223634A1 (de) |
| DE (1) | DE60326773D1 (de) |
| ES (1) | ES2322451T3 (de) |
| WO (1) | WO2004098584A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY147767A (en) | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
| EP1881959A1 (de) | 2005-05-20 | 2008-01-30 | Janssen Pharmaceutica N.V. | Verfahren zur herstellung von sulfamidderivaten |
| US8937096B2 (en) | 2005-12-19 | 2015-01-20 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder |
| US8492431B2 (en) | 2005-12-19 | 2013-07-23 | Janssen Pharmaceutica, N.V. | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity |
| US8716231B2 (en) | 2005-12-19 | 2014-05-06 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
| US8497298B2 (en) | 2005-12-19 | 2013-07-30 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
| JP2009537635A (ja) | 2006-05-19 | 2009-10-29 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 癲癇の処置のための共同−療法 |
| BRPI0915890A2 (pt) | 2008-06-23 | 2015-11-03 | Janssen Pharmaceutica Nv | forma cristalina de (2s)-(-)-n-(6-cloro-2,3-di-hidro-benzo[1,4]dioxin-2-ilmetil)-sulfamida |
| US8815939B2 (en) | 2008-07-22 | 2014-08-26 | Janssen Pharmaceutica Nv | Substituted sulfamide derivatives |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5985900A (en) * | 1997-04-01 | 1999-11-16 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
| JP2002322197A (ja) * | 2001-04-24 | 2002-11-08 | Senju Pharmaceut Co Ltd | ペプチジルヒドロキサム酸誘導体およびその用途 |
| DE60330038D1 (de) * | 2002-07-22 | 2009-12-24 | Senju Pharma Co | Neue alpha-ketoamidderivate und deren verwendung |
-
2003
- 2003-04-16 JP JP2004571636A patent/JP4373343B2/ja not_active Expired - Fee Related
- 2003-04-16 DE DE60326773T patent/DE60326773D1/de not_active Expired - Lifetime
- 2003-04-16 US US10/553,142 patent/US7375120B2/en not_active Expired - Fee Related
- 2003-04-16 ES ES03719773T patent/ES2322451T3/es not_active Expired - Lifetime
- 2003-04-16 EP EP03719773A patent/EP1615629B1/de not_active Expired - Lifetime
- 2003-04-16 AU AU2003223634A patent/AU2003223634A1/en not_active Abandoned
- 2003-04-16 WO PCT/US2003/011704 patent/WO2004098584A1/en active Application Filing
- 2003-04-16 AT AT03719773T patent/ATE425962T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003223634A1 (en) | 2004-11-26 |
| EP1615629A1 (de) | 2006-01-18 |
| ES2322451T3 (es) | 2009-06-22 |
| EP1615629B1 (de) | 2009-03-18 |
| US7375120B2 (en) | 2008-05-20 |
| US20060229341A1 (en) | 2006-10-12 |
| JP2006523612A (ja) | 2006-10-19 |
| DE60326773D1 (de) | 2009-04-30 |
| EP1615629A4 (de) | 2007-02-28 |
| WO2004098584A1 (en) | 2004-11-18 |
| JP4373343B2 (ja) | 2009-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20054453D0 (no) | P38 inhibitorer og fremgangsmater for anvendelse derav | |
| DK1606283T3 (da) | P38-inhibitorer og fremgangsmåder til anvendelse deraf | |
| DE602004018837D1 (de) | Ptidase-iv-inhibitoren | |
| MY133625A (en) | Peptide deformylase inhibitors | |
| UY27192A1 (es) | Inhibidores de peptido-deformilasa | |
| ATE425962T1 (de) | Peptid-deformylase-hemmer | |
| NO20053071L (no) | Kalsilytiske forbindelser. | |
| NO20025281L (no) | Peptid-deformylase-inhibitorer | |
| ATE548037T1 (de) | Peptid-deformylase-hemmer | |
| WO2004052919A3 (en) | Peptide deformylase inhibitors | |
| DE60207833D1 (de) | Peptiddeformylase-hemmer | |
| WO2007016364A3 (en) | Peptide deformylase inhibitors | |
| ATE514683T1 (de) | Peptid-deformylase-hemmer | |
| WO2005005456A3 (en) | Peptide deformylase inhibitors | |
| DE60207384D1 (de) | Peptid-deformylase-hemmer | |
| ATE433953T1 (de) | Peptiddeformylaseinhibitoren | |
| ATE531690T1 (de) | Inhibitoren von peptiddeformylase | |
| WO2002070653A3 (en) | Peptide deformylase inhibitors | |
| WO2005017124A3 (en) | Peptide deformylase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |